Northwestern University researchers have successfully coaxed a deadly pathogen to destroy itself from the inside out.
Novavax’s protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows
Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing